Please provide your email address to receive an email when new articles are posted on . SAN DIEGO — Clinical trials exploring intravenous immunoglobulin and Janus kinase inhibition headline a robust ...

Idiopathic inflammatory myopathies (IIMs) comprise a group of inflammatory disorders in which there is chronic inflammation of skeletal muscle. This is then followed by muscle weakness. One type of ...

Inflammatory myopathies are immunological diseases that lead to inflammations in muscular tissue. As of yet, little is known about the cause of these myopathies, but it is believed to be an abnormal ...

Muscular dystrophy is a type of disease that causes the muscles in your body to lose strength and mass. As your muscles become weaker over time, it may be hard for you to do normal activities.

Please provide your email address to receive an email when new articles are posted on . Dermatomyositis, older age and anti-transcriptional intermediary factor-1 gamma positivity are associated with a ...

Hanadie Yousef, PhD, co-founder and CEO of Juvena Therapeutics, explores the potential synergy between myopathies and obesity in terms of patient populations and underlying biological mechanisms. In ...

NEW findings reinforce that fatigue is not just a secondary symptom in myositis, but a central feature of disease activity that should be routinely assessed in both clinical care and research.

A new study has suggested that treatment to target necroptosis in muscle fibers using a necroptosis inhibitor lessens myositis-induced muscle weakness as well as muscle cell death and inflammation in ...

2nd edition Edited by: ISBN: 978-0-19-987393-7 Published by Oxford University Press Retail price: £97.00/$149.95 The new edition of Evaluation and Treatment of Myopathies focuses on the clinical ...

ARMGO Pharma Publishes Positive Phase 1b Trial Results of Rycal ® ARM210 for the Treatment of Ryanodine Receptor 1 Related Myopathies Phase 1b open label trial confirms safety and tolerability of 120 ...

Idiopathic inflammatory myopathies (IIM) represent a heterogeneous group of autoimmune disorders primarily characterised by progressive muscle weakness and inflammation, but with potential involvement ...

According to DelveInsight's analysis, the market size for mitochondrial myopathies was found to be USD 433 million in the leading markets [the United States, the EU4 (Germany, France, Italy, and Spain ...